普通口服固体制剂溶出度试验技术指导原则(国家食品药品监管总局通告2015年第3号) ... ...

2023-4-6 12:45| 发布者: 享瑾美| 查看: 563| 评论: 0|来自: 国家药监局

摘要: 本则适用于普通口服固体制剂,包括:1)溶出度试验的一般要求;2)根据生物药剂学特性建立溶出度标准的方法;3)溶出曲线比较的统计学方法;4)体内生物等效性试验豁免(即采用体外溶出度试验代替体内生物等效性试验 ...


参考文献

1.Amidon, G. L., H. Lennernas, V. P. Shah, and J. R. Crison, 1995, “A Theoretical Basis For a Biopharmaceutic Drug Classification: The Correlation of In Vitro Drug ProductDissolution and In Vivo Bioavailability,” Pharmaceutical Research, 2:413-420.

2.FDA, 1995, Center for Drug Evaluation and Research, Guidance for Industry: ImmediateRelease Solid Oral Dosage Forms. Scale-up and Post-Approval Changes: Chemistry,Manufacturing and Controls, In Vitro Dissolution Testing, and In Vivo Bioequivalence

Documentation [SUPAC-IR], November 1995.

3.Meyer, M. C., A. B. Straughn, E. J. Jarvi, G. C. Wood, F. R. Pelsor, and V. P. Shah, 1992,“The Bioequivalence of Carbamazepine Tablets with a History of Clinical Failures,”Pharmaceutical Research, 9:1612-1616.

4.Moore, J. W. and H. H. Flanner, 1996,“Mathematical Comparison of Dissolution Profiles,”Pharmaceutical Technology, 20 (6):64-74.

5.Shah, V. P., et al., 1989, “In Vitro Dissolution Profile of Water Insoluble Drug Dosage Forms inthe Presence of Surfactants,”Pharmaceutical Research, 6:612-618.

6.Shah, V. P., et al., 1992,“Influence of Higher Rate ofAgitation on Release Patterns of Immediate Release Drug Products,”Journal of Pharmaceutical Science, 81:500-503.

7.Shah, V. P., J. P. Skelly, W. H. Barr, H. Malinowski, and G. L. Amidon, 1992,“Scale-up of Controlled Release Products –PreliminaryConsiderations,”Pharmaceutical Technology, 16(5):35-40.

8.Shah, V. P., et al., 1995,“In Vivo Dissolution of Sparingly Water Soluble Drug Dosage Forms,” International Journal of Pharmaceutics, 125:99-106.

9.Siewert, M., 1995,“FIP Guidelines for Dissolution Testing of Solid Oral Products,”Pharm.Ind. 57:362-369.

10. Skelly, J. P., G. L. Amidon, W. H. Barr, L. Z. Benet, J. E. Carter, J. R. Robinson, V. P. Shah, and A. Yacobi, 1990,“In Vitro and In Vivo Testing and Correlation for Oral Controlled/Modified-Release Dosage Forms,”Pharmaceutical Research, 7:975-982.

11. 国家食品药品监督管理局,已上市化学药品变更研究的技术指导原则(一),2008.

12.中国药典2010版二部附录,溶出度测定法。

13. British Pharmacopeia 2012Dissolution test for tablets and capsules.

12345

路过

雷人

握手

鲜花

鸡蛋


本站信息仅供参考,不能作为诊断医疗依据,所提供文字图片视频等信息旨在参考交流,如有转载引用涉及到侵犯知识产权等问题,请第一时间联系我们处理

在线客服|关于我们|移动客户端 | 手机版|电子书籍下载|中医启疾光网 (鄂ICP备20008850号 )

Powered by Discuz! X3.5 © 2001-2013 Comsenz Inc. Designed by zyqjg.com

版权

返回顶部